RecruitingPhase 3NCT07496450
A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults
Studying Avian influenza
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- ModernaTX, Inc.
- Intervention
- mRNA-1018-H5(biological)
- Enrollment
- 4000 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2026 – 2027
Study locations (30)
- Velocity Clinical Research, San Bernardino, San Bernardino, California, United States
- Velocity Clinical Research, Savannah, Savannah, Georgia, United States
- Velocity Clinical Research, Boise, Meridian, Idaho, United States
- Velocity Clinical Research, Rockville, Rockville, Maryland, United States
- Velocity Clinical Research, Omaha, Omaha, Nebraska, United States
- Velocity Clinical Research, Cleveland, Beachwood, Ohio, United States
- Velocity Clinical Research, Providence, East Greenwich, Rhode Island, United States
- Velocity Clinical Research, Anderson, Anderson, South Carolina, United States
- Velocity Clinical Research, Dallas, Dallas, Texas, United States
- Velocity Clinical Research, Suffolk, Suffolk, Virginia, United States
- Velocity Clinical Research-Bristol, Bristol, Bristol (Unitary Authority), United Kingdom
- Velocity Clinical Research - High Wycombe, High Wycombe, Buckinghamshire, United Kingdom
- Wansford Research Ltd, Peterborough, Cambridgeshire, United Kingdom
- Futuremeds Teesside Middlefield Centre University Hospital of North Tees, Stockton-on-Tees, County Durham, United Kingdom
- NIHR Wessex CRDC - Bournemouth Research Hub (Under University Hospital Southampton NHS Foundation Trust), Bournemouth, Dorset, United Kingdom
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07496450 on ClinicalTrials.govOther trials for Avian influenza
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07240558Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial)University Health Network, Toronto
- ACTIVE NOT RECRUITINGPHASE4NCT07275060Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks ApartCanadian Immunization Research Network
- RECRUITINGPHASE1, PHASE2NCT06842173Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older AdultsButantan Institute
- ACTIVE NOT RECRUITINGPHASE1NCT07019883A Study to Evaluate the Safety and Immunogenicity of Two Doses of a Novel H5 Central Antigen mRNA-LNP in Healthy AdultsNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGNANCT06850298H5N1 Milk Detection StudyEmory University